We are live on ! Find out more
VF

Virtu Financial Portfolio holdings

AUM $3.18B
1-Year Est. Return 65.92%
This Fund
S&P 500
This Quarter Est. Return
+4.3%
1 Year Est. Return
+65.92%
3 Year Est. Return
+160.27%
5 Year Est. Return
+179.96%
10 Year Est. Return
AUM
$1.89B
AUM Growth
-$132M
Cap. Flow
-$177M
Cap. Flow %
-9.36%
Top 10 Hldgs %
13.63%
Holding
3,498
New
1,025
Increased
629
Reduced
628
Closed
1,190

Sector Composition

Rank Sector Weight
1 Financials 8.89%
2 Technology 5.8%
3 Healthcare 5.75%
4 Consumer Discretionary 5.73%
5 Energy 5.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CATX icon
2201
Perspective Therapeutics
CATX
$354M
$22K ﹤0.01%
5,491
+1,229
+29% +$5.72K
CRDF icon
2202
Cardiff Oncology
CRDF
$76.6M
$22K ﹤0.01%
996
-102
-9% -$4.52K
LTRX icon
2203
Lantronix
LTRX
$272M
$22K ﹤0.01%
+10,848
New +$21.9K
OPTT icon
2204
Ocean Power Technologies
OPTT
$55.4M
$22K ﹤0.01%
988
+33
+3% +$817
AAU
2205
DELISTED
Almaden Minerals Ltd
AAU
$22K ﹤0.01%
21,648
+2,641
+14% +$2.63K
BDR
2206
DELISTED
Blonder Tongue Laboratories Inc
BDR
$22K ﹤0.01%
36,830
+13,426
+57% +$6.44K
IPCI
2207
DELISTED
Intellipharmaceuticals International Inc.
IPCI
$22K ﹤0.01%
+2,763
New +$25.1K
INUV icon
2208
Inuvo
INUV
$14.2M
$21K ﹤0.01%
2,636
+1,551
+143% +$13.4K
PRPO icon
2209
Precipio
PRPO
$41.5M
$21K ﹤0.01%
58
-89
-61% -$40.2K
TAIT
2210
DELISTED
Taitron Components
TAIT
$21K ﹤0.01%
12,454
-27,468
-69% -$45.4K
SEEL
2211
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
0
AEY
2212
DELISTED
ADDvantage Technologies Group
AEY
$21K ﹤0.01%
+1,408
New +$20.6K
ATHX
2213
DELISTED
Athersys, Inc. Common Stock
ATHX
$21K ﹤0.01%
453
-3,087
-87% -$149K
ZSAN
2214
DELISTED
Zosano Pharma Corporation
ZSAN
$21K ﹤0.01%
59
+14
+31% +$7.03K
AIM
2215
AIM ImmunoTech
AIM
$7.17M
$21K ﹤0.01%
14
+9
+180% +$12.9K
GEVO icon
2216
Gevo
GEVO
$401M
$20K ﹤0.01%
1,705
-12,116
-88% -$155K
MVIS icon
2217
Microvision
MVIS
$89.7M
$20K ﹤0.01%
806
-2,829
-78% -$81.7K
CHCI icon
2218
Comstock Holding Companies
CHCI
$173M
$19K ﹤0.01%
+11,372
New +$17.9K
EMX
2219
DELISTED
EMX Royalty
EMX
$19K ﹤0.01%
22,714
+2,211
+11% +$1.72K
SSY
2220
DELISTED
SunLink Health Systems
SSY
$19K ﹤0.01%
+11,967
New +$18.5K
URG
2221
Ur-Energy
URG
$533M
$19K ﹤0.01%
27,161
-1,537
-5% -$936
VXRT
2222
DELISTED
Vaxart
VXRT
$19K ﹤0.01%
3,019
-5,443
-64% -$38K
TRAW icon
2223
Traws Pharma
TRAW
$9.14M
$19K ﹤0.01%
2
-4
-67% -$41.2K
YVR
2224
DELISTED
Liquid Media Group Ltd. Common Shares
YVR
$19K ﹤0.01%
+569
New +$18.8K
NXTDW
2225
DELISTED
Nxt-ID, Inc.
NXTDW
$19K ﹤0.01%
28,457
+5,735
+25% +$1.31K

Similar funds

Virtu Financial's Q4 2017 Portfolio in Review

As of Q4 2017, Virtu Financial held 3,498 positions worth $1.89B, down 6.5% from $2.02B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Virtu Financial withdrew a net $177M in Q4 2017, closing 1,190 positions and reducing 628 holdings. Its most notable exit was Astoria Financial Corporation, an estimated $20.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 8.9% of assets, up from 6.9% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Virtu Financial opened a new position in UBS E-TRACS Alerian MLP Infrastructure ETN worth $20.6M.

  • Virtu Financial's largest Q4 2017 buy was UBS E-TRACS Alerian MLP Infrastructure ETN: 852,961 shares worth $20.6M.
  • Virtu Financial added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $34.8M increase.
  • Virtu Financial's biggest Q4 2017 reduction was VanEck Gold Miners ETF, cutting an estimated $60.7M.
  • Virtu Financial fully exited Astoria Financial Corporation in Q4 2017, selling an estimated $20.7M.
  • Virtu Financial's ten largest holdings make up 14% of its $1.89B portfolio in Q4 2017.
  • Virtu Financial opened 1,025 new positions and closed 1,190 in Q4 2017.
  • Virtu Financial's portfolio value fell 6.5% quarter-over-quarter to $1.89B.

Based on Virtu Financial's 13F filing for Q4 2017, filed 9 Feb 2018.